Josep Carreras Leukaemia Research Institute open call for Director

The new Director should define the overall scientific, technological and innovation vision for the institute

The new director is expected to foster a stimulating environment for interdisciplinary and translational research in leukaemia and other malignant haematological diseases. Additionally, they must promote an institutional culture that integrates collaboration, communication, integrity, transparency, collegiality, and scientific creativity, with the ultimate goal of finding a cure for leukaemia and other malignant haematological diseases.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

Share

More news

  • CERCA system
The Fundació Recerca Clínic Barcelona – Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) is a biomedical research institute of excellence in Barcelona promoted by…